MK-0000-158

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0000-158, covering 2011-11-24 to 2011-11-24. Get the full timeline:

Most recent: Clinical Trial Update: The OBSTACLE Hypoglycemia Study (MK-0000-158)